
FRIDAY, March 17, 2023 (HealthDay News) -- Just like adults, young children with type 1 diabetes may get the blood sugar control they need using an "artificial pancreas," new research shows. The Control-IQ artificial pancreas system was tested in a clinical trial in children aged 2 to 6. Using the technology developed at the University of Virginia (UVA), these children spent approximately three more hours per day in their target blood sugar range compared with those in a control group.“After the resounding success of Control-IQ technology in people ages 6 and up, it is very rewarding to see our youngest patients, and often the most challenging patients to help, benefit as well,†said study author Marc Breton, a UVA School of Medicine researcher. “With these results, we have now...